These 5 surgical startups want to build the OR of the future

As with most medtech advances these days, a running theme among top surgical startups is value. Innovators presented their surgical platform products in various stages of development at this year’s AdvaMed MedTech Conference as part of the Medtech Innovator Program, offering a view of the future of ORs across the world. As mentioned, there are some running

Pages: 1 2 3 4 5 6

Theraclion touts Echopulse thyroid nodule treatment results

Theraclion says its Echopulse has shown improved outcomes when treating thyroid nodules when compared to surgical treatment, according to new published data. Three studies – led byDr. Brian Hung-Hin Lang, chief of the endocrine surgery division at Queen Mary University Hospital in Hong Kong – showed the efficiency of using the Echopulse for non-invasive treatment

Medtech stories we missed this week: June 2, 2017

From Implandata receiving CE Marking to Inolife eyeing up-listing, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Dextera seeks expanded indications for MicroCutter 5/80 stapler Dextera Surgical announced in a June 1 press release that it has filed a 510(k) with the FDA for its MicroCutter 5/80 stapler. The

Medtech stories we missed this week: May 26, 2017

From Merck’s new licensing agreement to surgical study data being touted, here are medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. The

Artificial intelligence accurately predicts stroke risk

Machine-learning algorithms, a form of artificial intelligence, accurately predicted people’s risk of heart disease and stroke, according to new research from the University of Nottingham. Researchers and computer scientists compared the risk guidelines for heart disease and stroke from the American College of Cardiology with 4 machine-learning algorithms to analyze the risk of a patient

Why adding device identifiers to insurance claims protects patients

The pushback to adopting unique device identifier into claims forms is that the added steps will be burdensome for hospitals. But documenting device identifiers in claims forms is actually “feasible” and “straightforward,” and requires only modest effort, according to a new whitepaper from Boston’s Brigham and Women’s Hospital. Of particular concern was that the device claims

Medtech stories we missed this week: May 19, 2017

From FDA clearances to touting study data, here are some medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. The

Medtech stories we missed this week: May 12, 2017

From Bioness’s new distribution deal to InBrace’s launch of new braces technology, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Obalon receives approval to commercialize in Middle East Obalon Therapeutics announced in a May 11 press release that it has received regulatory approvals in select Middle East

Sepsis causes most hospital readmissions

A University of Pittsburgh School of Medicine and VA Pittsburgh Healthcare System analysis recently showed that sepsis results in more hospital readmissions and costs than any of the other 4 medical conditions that the government tracks for quality of care and guide pay-for-performance reimbursements. The results should provide food for thought for medical device developers

How deep learning algorithms could detect diabetic eye disease

Researchers at the Byers Eye Institute at Stanford University believe deep learning algorithms, a form of artificial intelligence, hold the key to detecting diabetic retinopathy and averting blindness in patients. Diabetic retinopathy damages the blood vessels at the back of the eye and is the leading cause of preventable blindness globally. Up to 45% of

Skin sensors provide insights into how to treat Parkinson’s

A University of Rochester research team is using wearable sensors to indicate the best individualized treatment of Parkinson’s disease. Bernadette Mroz suffers from Parkinson’s. When her medication isn’t working, it makes it hard for her to function. “My world goes into a spin cycle. I cannot function mentally, emotionally or physically,” said Mroz in a

Cybersecurity: Is medtech ‘lackadaisical’ about it?

The medical device industry needs to shake itself out of its stupor when it comes to cybersecurity, according to James Scott, senior fellow at the Institute for Critical Infrastructure Technology and author of the new paper, How to Crush the Health Sector’s Ransomware Pandemic. Companies in the medtech sector and the overall healthcare space face

Edge computing: It’s what healthcare IoT craves

Ever hear of edge computing? If you’re in healthcare, you will soon if you haven’t already, according to experts. The reason is IoT. IoT devices such as fitness wearables, glucose monitors, telehealth tools and other sensors are poised to revolutionize health. But there are some barriers that are keeping IoT from realizing its full potential

Medtech stories we missed this week: March 3, 2017

Several clinical study results were published this week, while other companies reached distribution deals. Here are some medtech stories we missed this week but were still worth mentioning. 1. Health Canada approves Ventripoint’s complete heart analysis system for 2D ultrasounds Ventripoint Diagnostics received a license from Health Canada for its new VMS-Plus machine and the 4-chamber

Blood test could accurately diagnose heart disease

A simple blood test could accurately diagnose heart disease in 2 hours, according to new data published by life science company Prevencio. Prevencio researchers and the Massachusetts General Hospital collaborated to develop a clinical and multi-protein blood test that could diagnose obstructions in coronary arteries, leading to the prevention of a heart attack. The blood test, known